QuintilesIMS Real-World Insights Bibliography

An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries.
Author(s): Turini M1, Piovesana V1, Ruffo P1, Ripellino C2, Cataldo N2.
Affiliations(s): 1 Helsinn S A., Lugano, Switzerland, 2 IMS Health Information Solutions Medical Research srl, Milan, Italy.
Publication(s): Drugs Context. 28;4:212285.
Document Type(s): Article
Countries: France, Germany, Italy
Click here for the abstract
C:
Y:
Health economics, Oncology
2015
  L:
A:
English
Survey research
  Add to report
 
 
A cost-effectiveness evaluation comparing biosimilar Bemfola to Gonal-f for the treatment of infertility in an Italian contest.
Author(s): Ripellino C1, Visentin E1, Gizzo S2, Bühler K3
Affiliations(s): 1 IMS Health Information Solutions Medical Research S.r.l, Milan, Italy 2 University of Padua, padua, Italy 3 Centre for Gynaecology, Endocrinology and Reproductive Medicine, Ulm and Stuttgart, Germany
Publication(s): ISPOR Annual European Congress. Milan, Italy.
Document Type(s): Poster
Countries: Italy
C:
Y:
Health economics, Pregnancy
2015
  L:
A:
English
Cost analysis, Economic evaluation
  Add to report
 
 
Access to New Medicines in Public Drug Plans: Canada and Comparable Countries 2015 Annual Report
Author(s): Millson B1, Thiele S1, Zhang Y1, Dobson-Belaire W1, Skinner B2
Affiliations(s): 1 IMS Health Canada Inc., 16720 Trans-Canada Highway, Kirkland, Quebec H9H 5M3 2 Innovative Medicines Canada, 55 Metcalfe Street, Suite 1220, Ottawa, Ontario K1P 6L5
Publication(s): Innovative Medicines Canada Annual Report 2016
Document Type(s): Report
Countries: Canada
Click here for the abstract
C:
Y:
Health economics, Health policy
2015
  L:
A:
English
Review
  Add to report
 
 
Health economic burden that wounds impose on the National Health Service in the UK
Author(s): Guest JF, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D, Vowden K, Vowden P
Affiliations(s): Catalyst Health Economics Consultants, Northwood,; Bradford Teaching Hospitals NHS Foundation Trust and University of Bradford
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Health economics, Injuries
2015
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
A cost comparison of long-acting insulin analogs vs NPH insulin-based treatment in patients with type 2 diabetes using routinely collected primary care data from the UK
Author(s): Idris I, Gordon J, Tilling C, Vora J
Affiliations(s): Division of Medical Sciences & Graduate Entry Medicine, University of Nottingham
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Diabetes, Health economics
2015
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Big data, advanced analytics and the transformation of healthcare delivery: Practical applications in healthcare research
Author(s): Keja J1, Incardona F2, Blunt I3, Rigg J1
Affiliations(s): 1 Real-World Evidence Solutions & HEOR, IMS Health, London, UK 2 Italian Parliamentary Commission on Medical Errors, and Expert Evaluator, European Commission, Rome, Italy 3 The Nutfield Trust, London, UK
Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Type(s): Symposium
Countries: 
C:
Y:
Health economics
2014
  L:
A:
English
Real World Data
  Add to report
 
 
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
Author(s): Lebioda A1, Gasche D2, Dippel F-W3, Theobald K4, Plantör S1
Affiliations(s): 1 IMS Health,Munich, Germany 2 IMS Health, Barcelona, Spain 3 Sanofi-Aventis Deutschland GmbH, Berlin, Germany 4 Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany
Publication(s): Health Economics Review, 2014, 4(31)
Document Type(s): Article
Countries: Germany
Click here for the abstract
C:
Y:
Health economics
2014
  L:
A:
English
Methodology
  Add to report
 
 
Evidence-based insights in oncology: The journey is only just beginning
Author(s): Ghai C
Affiliations(s): RWE Solutions & HEOR, IMS Health, New York, USA
Publication(s): AccessPoint, 2014, May; 4(8): 14-20
Document Type(s): Article
Countries: USA
Click here for the abstract
C:
Y:
Health economics, Oncology
2014
  L:
A:
English
Real World Evidence
  Add to report
 
 
Patient-reported outcomes assessment
Author(s): Crawford B1, Luo N2
Affiliations(s): 1 Real World Evidence Solutions, Japan & APAC, IMS Health KK, Tokyo, Japan 2 Saw Swee Hock School of Public Health, National University of Singapore, Singapore
Publication(s): ISPOR 6th Asia-Pacific Conference, Beijing, China, 6-9 September, 2014 (short course)
Document Type(s): Workshop
Countries: 
Click here for the abstract
C:
Y:
Health economics
2014
  L:
A:
English
Real World Evidence
  Add to report
 
 
Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.
Author(s): Caresano C1, Di Sciascio G2, Fagiolini A3, Maina G4, Perugi G5, Ripellino C6, Vampini C7.
Affiliations(s): 1 Department of Psychiatry, Lundbeck Italia S.p.A, Milan, Italy, 2 Department of Psychiatry, Policlinico Hospital, Bari, Italy, 3 Department of Molecular Medicine, University of Siena, Siena, Italy, 4 Department of Neurosciences, University of Torino, Turin, Italy, 5 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 6 Institute of Behavioural Sciences ‘‘G. De Lisio’’, Pisa, 7 CSD Medical Research S.R.L., Milan, Italy, 8 Department of Mental Health, Ospedale Civile Maggiore, Verona, Italy.
Publication(s): Adv Ther. 2014 Aug;31(8):873-90. doi: 10.1007/s12325-014-0139-3. Epub 2014 Jul 24
Document Type(s): Article
Countries: Italy
Click here for the abstract
C:
Y:
Health economics, Mental health
2014
  L:
A:
English
Cost effectiveness
  Add to report
 
 
First Page Previous Page  2 of 14 Next Page Last Page